Showing results (61-70 of 231) with videos related to
Sort By:
Pageof 24
European Neurology|January 1, 1996
Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarctsF Pasquier, D Leys, J G Weerts, et al.AJNR. American Journal of Neuroradiology|August 1, 1997
Test-retest analysis with functional MR of the activated area in the human visual cortexS A Rombouts, F Barkhof, F G Hoogenraad, et al.Dementia and Geriatric Cognitive Disorders|May 1, 1997
Diagnosing Alzheimer's disease in community-dwelling elderly: a comparison of EEG and MRIR L Strijers, P Scheltens, E J Jonkman, et al.Journal of the Neurological Sciences|October 20, 1999
Normal cerebrospinal fluid glutathione concentrations in Parkinson's disease, Alzheimer's disease and multiple system atrophyC H Konings, M A Kuiper, T Teerlink, et al.Annals of the New York Academy of Sciences|May 20, 2000
Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementiaC Ballard, J O'Brien, B Barber, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 23, 2000
Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot studyH W Berendse, J P Verbunt, P Scheltens, et al.Neurology|April 11, 2007
Physical activity and white matter lesion progression: assessment using MRIL J Podewils, E Guallar, N Beauchamp, et al.Hippocampus|January 1, 1997
Visual association encoding activates the medial temporal lobe: a functional magnetic resonance imaging studyS A Rombouts, W C Machielsen, M P Witter, et al.Lancet (London, England)|August 22, 2001
Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled studyW A Van Gool, H C Weinstein, P Scheltens, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 24, 2019
In pursuit of a sensitive EEG functional connectivity outcome measure for clinical trials in Alzheimer's diseaseC T Briels, C J Stam, P Scheltens, et al.Pageof 24